PRECIGEN, INC. (PGEN) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 93.88M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 170.30M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $93.88M | (m) | (m) | $170.30M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $93.52M | (m) | (m) | $138.63M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $93.17M | (m) | (m) | $155.50M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $145.27M | (m) |
| 2022-12-31 | (m) | (m) | $43.22M | $0.00 | (m) | (m) | $215.98M | (m) |
| 2022-09-30 | (m) | (m) | $82.07M | $0.00 | (m) | (m) | $259.25M | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | $198.67M | (m) | (m) | $321.22M | (m) |
| 2022-03-31 | (m) | (m) | $355.00K | $201.11M | (m) | (m) | $335.57M | (m) |
| 2021-12-31 | (m) | (m) | $402.00K | $182.75M | (m) | (m) | $359.86M | (m) |
| 2021-09-30 | (m) | (m) | $355.00K | $179.82M | (m) | (m) | $376.90M | (m) |
| 2021-06-30 | (m) | (m) | $356.00K | $176.92M | (m) | (m) | $402.57M | (m) |
| 2021-03-31 | (m) | (m) | $359.00K | $174.16M | (m) | (m) | $406.98M | (m) |
| 2020-12-31 | (m) | (m) | $360.00K | $171.52M | (m) | (m) | $314.59M | (m) |
| 2020-09-30 | (m) | (m) | $421.00K | $193.80M | (m) | (m) | $336.19M | (m) |
| 2020-06-30 | (m) | (m) | $32.11M | $191.21M | (m) | (m) | $361.71M | (m) |
| 2020-03-31 | (m) | (m) | $31.89M | $188.73M | (m) | (m) | $404.67M | (m) |
| 2019-12-31 | (m) | (m) | $31.67M | $186.32M | (m) | (m) | $455.76M | (m) |
| 2019-09-30 | (m) | (m) | $31.43M | $184.03M | (m) | (m) | $604.90M | (m) |
| 2019-06-30 | (m) | (m) | $468.00K | $212.48M | (m) | (m) | $655.19M | (m) |
| 2019-03-31 | (m) | (m) | $564.00K | $214.01M | (m) | (m) | $709.86M | (m) |
| 2018-12-31 | (m) | (m) | $559.00K | $211.24M | (m) | (m) | $716.18M | (m) |
| 2018-09-30 | (m) | (m) | $546.00K | $183.13M | (m) | (m) | $980.41M | (m) |
| 2018-06-30 | (m) | (m) | $489.00K | $7.27M | (m) | (m) | $825.15M | (m) |
| 2018-03-31 | (m) | (m) | $501.00K | $7.42M | (m) | (m) | $895.67M | (m) |
| 2017-12-31 | (m) | (m) | $502.00K | $7.54M | (m) | (m) | $846.85M | (m) |
| 2017-09-30 | (m) | (m) | $439.00K | $7.67M | (m) | (m) | $898.26M | (m) |
| 2017-06-30 | (m) | (m) | $434.00K | $7.68M | (m) | (m) | $933.99M | (m) |
| 2017-03-31 | (m) | (m) | $388.00K | $7.61M | (m) | (m) | $915.93M | (m) |
| 2016-12-31 | (m) | (m) | $386.00K | $7.56M | (m) | (m) | $949.07M | (m) |
| 2016-09-30 | (m) | (m) | $471.00K | $7.95M | (m) | (m) | $1.01B | (m) |
| 2016-06-30 | (m) | (m) | $491.00K | $7.53M | (m) | (m) | $1.03B | (m) |
| 2016-03-31 | (m) | (m) | $893.00K | $7.61M | (m) | (m) | $962.43M | (m) |
| 2015-12-31 | (m) | (m) | $930.00K | $7.60M | (m) | (m) | $982.05M | (m) |
| 2015-09-30 | (m) | (m) | $1.31M | $7.80M | (m) | (m) | $989.89M | (m) |
| 2015-06-30 | (m) | (m) | $1.43M | $8.04M | (m) | (m) | $792.94M | (m) |
| 2015-03-31 | (m) | (m) | $1.43M | $8.30M | (m) | (m) | $819.99M | (m) |
| 2014-12-31 | (m) | (m) | $1.68M | $8.69M | (m) | (m) | $576.27M | (m) |
| 2014-09-30 | (m) | (m) | $1.49M | $9.43M | (m) | (m) | $538.50M | (m) |
| 2014-06-30 | (m) | (m) | (m) | $2.00M | (m) | (m) | $500.54M | (m) |
| 2014-03-31 | (m) | (m) | (m) | $1.78M | (m) | (m) | $547.81M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $1.65M | (m) | (m) | $469.47M | (m) |
| 2013-09-30 | (m) | (m) | $211.00K | $2.31M | (m) | (m) | $474.20M | (m) |
| 2013-06-30 | (m) | (m) | $223.00K | $2.07M | (m) | (m) | $283.45M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |